1 recruiting, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Recruiting 1, Withdrawn 1 |
Follow Neurocognitive testing: new trials by email Literature Review of Neurocognitive testing trials Research Report on Neurocognitive testing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis AAV9-GLB1, Abdominal ultrasound, Rituximab - Lysosomal Diseases, Gangliosidosis | Phase 1 / Phase 2 | Recruiting | National Human Genome Research Institute (NHGRI) | 54 | 2019-08-19 | 2026-09-21 |
| The Effect of Obstructive Sleep Apnea on Medical Outcomes After Gastric Bypass Surgery Neurocognitive Testing - Obesity, Sleep Apnea, Obstructive | Phase 1 / Phase 2 | Withdrawn | Stanford University | 2010-03-01 | 2016-10-18 |
Gangliosidoses (1) · Obesity (1) · Sleep Apnea, Obstructive (1)
National Human Genome Research Institute (NHGRI) (1) · Stanford University (1)
United States (2)
Anthony Doufas (1) · Cynthia J Tifft, M.D. (1)